Bioextrax AB engages in the development and commercialization of bio-extraction platform technology. It develops, tests, and verifies a potent microbial strain that can extract a variety of pure polyhydroxyalkanoates (PHA) bio-plastic granules from different PHA producing bacteria. Its technology is based on the selective lysis of microbial cell walls under mild conditions using a novel proprietary microbial isolate. The company was founded by Mohammad Hamed Ahmad Ibrahim and Rajni Hatti-Kaul on February 6, 2014 and is headquartered in Lund, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company